| Financial Year |
March 31 2023 |
| Monetary Funds |
973,510,301.00 |
| Held-for-trading Financial Assets |
495,663,687.51 |
| Notes Receivable |
103,663,605.34 |
| Accounts Receivable |
460,878,023.27 |
| Advances to Suppliers |
73,497,275.43 |
| Other Receivables |
69,818,438.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
30,549,575.34 |
| Dividend Receivable |
-- |
| Inventories |
788,805,196.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,086,873.93 |
| Total Current Assets |
2,985,750,503.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
600,000,000.00 |
| Long-term Equity Investment |
-- |
| Investment Properties |
354,593.99 |
| Fixed Assetes |
846,187,219.61 |
| Under-construction Projects |
427,883,249.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
196,550,565.79 |
| R&D expenses |
83,482,640.29 |
| Goodwill |
2,614,611,614.12 |
| Long-Term Deferred and Prepaid Expenses |
8,628,194.45 |
| Deferred Income Tax Assets |
46,034,412.44 |
| Other Non-Current Assets |
81,391,821.68 |
| Sub-Total of Non-Current Assets |
4,940,080,224.25 |
| Total Assets |
7,925,830,728.13 |
| Short-Term Loans |
271,297,113.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
115,509,146.31 |
| Accounts Received In Advance |
52,380.95 |
| Employee Compensation Payable |
22,630,318.54 |
| Taxes Payable |
28,110,079.62 |
| Interest Payable |
-- |
| Dividend Payable |
264,072.08 |
| Other payables |
322,076,571.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,277,016.30 |
| Other Current Liabilities |
6,830,752.98 |
| Sub-Total of Current Liabilities |
798,269,241.41 |
| Long-term Loans |
99,365,450.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
9,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
28,832,296.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
202,481,287.63 |
| Total Liabilities |
1,000,750,529.04 |
| Paid-In Capital(Or Share Stock) |
732,633,819.00 |
| Capital Surplus |
4,785,803,471.23 |
| Surplus Reserve |
105,670,841.00 |
| LESS:Treasury Stock |
36,215,522.15 |
| Undistributed Profits |
1,343,015,931.89 |
| Minority Stockholder's Interest |
-5,854,745.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,930,934,944.53 |
| Owner's Equity（Stockholder's Equity） |
6,925,080,199.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,925,830,728.13 |
